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ABSTRACT
Objective: To establish the prevalence of iron deficiency among children with cyanotic 
heart disease.
Design: Cross-sectional study.
Setting: The study was carried out at Kenyatta National Hospital and Mater Hospital 
from August to December of 2007. A total of 112 children meeting the eligibility criteria 
were recruited from the wards and the cardiac clinics.
Subjects: These were children less than 18 years of age, with cyanotic heart disease 
confirmed on ECHO, presenting at the paediatric cardiac clinic of the two hospitals 
or admitted in the wards at Kenyatta National Hospital. These were patients who had 
not undergone surgical correction.
Results: The prevalence of iron deficiency was found to be 16.9% (95% CI 9.8-
24.1%). 
Conclusion: There is a high prevalence of iron deficiency among patients with 
congenital heart disease with cyanosis in the two institutions. Routine screening for 
iron deficiency is recommended for these children and those found to be deficient 
should be treated.
INTRODUCTION 
Uncorrected congenital cyanotic heart lesions (and 
some acyanotic lesions which later have reversal of 
blood flow from right to left with the development 
of Eisenmenger’s complex) keep the body in a 
state of constant hypoxia. This hypoxia triggers 
a physiological increase in erythropoietin release 
leading to stimulation of the bone marrow to produce 
more red cells in an effort to increase the body’s oxygen 
carrying capacity, so as to improve oxygen delivery 
to the tissues. With persisting right to left shunt, the 
arterial oxygen tensions remain perpetually low and 
so the production of more and more red cells goes 
unabated leading to polycythemia. This seemingly 
noble physiological response eventually leads to 
depletion of iron stores. 
  In these patients, the total haemoglobin is normal, 
high or slightly reduced compared to aged-matched 
normal individuals without cyanosis. However, 
the MCV, MCH and serum ferritin are usually 
comparatively lower than their peers as shown by 
Cemile et al (1) - a phenomenon known as relative 
anaemia. Irrespective of cause, iron deficiency leads 
to a significant increase in whole blood viscosity 
in erythrocytotic patients, and the viscous effect 
rises with decreasing erythrocyte mean corpuscular 
haemoglobin (2). 
  Patients with iron deficiency will have higher 
morbidity rates presenting with symptoms of 
hyperviscosity such as cerebrovascular accidents, 
cyanotic spells, anorexia, exercise intolerance, poor 
appetite, poor weight gain, irritability and poor mental 
development. Treatment of iron deficiency has been 
shown to reverse all these symptoms. Gaiha  et al (3) 
showed that hyperviscosity symptoms occurred at a 
lower PCV level (0.52-0.58) among cyanotic patients 
with iron deficiency as compared to those who were iron 
sufficient where symptoms occurred at the mean PCV 
of 0.68. Among the iron deficient group, hyper cyanotic 
symptoms were relieved with iron supplements, and 
this symptomatic relief was accompanied by an average 
haemoglobin rise of 2.1g/dl (3). Similar effects were 
demonstrated by Perfloff   et al (4).
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MATERIALS AND METHODS
Study population: These were children less than 18 
years of age with ECHO confirmed cyanotic heart 
disease who had not undergone corrective surgery, 
presenting at the paediatric cardiac clinic of Kenyatta 
and Mater Hospitals or admitted in the wards at 
Kenyatta National Hospital. Those already on iron 
supplements were excluded from the study.
Sample size calculation: The sample size was calculated 
using Fischer’s method.
Sampling: Patients meeting the eligibility criteria 
were consecutively recruited from the two hospitals 
between 8 and 3 pm, till the desired sample size was 
attained.
Study duration: This study was carried out over five 
months  (August 2007 to December 2007).
Study design: This was a cross-sectional study. 
Procedures: Patients were identified and recruited 
into the study once consent was obtained. Body 
temperature was taken; height and length were 
measured in centimeters using a stadiometer. Weight 
was taken using a step-on weighing scale, or an 
infant weighing scale for infants. Date of birth, sex 
and residence was  recorded on the questionnaire. A 
history and physical examination was used to help 
exclude inflammatory disease which are known to 
affect ferritin levels.
  About 2ml of venous blood was drawn using a 
5cc syringe and divided equally into a plain bottle 
and EDTA bottle. The complete blood count was 
done using the electronic cell counter – Cell-Dyn 
1300. Ferritin levels were performed using a semi 
automated process using Humalyzer 2000.
Study definitions 
(i) Iron deficiency: Depletion of the body’s iron stores 
as evidenced by low ferritin levels that are below 
the lower limit of the age specific reference range 
(5). In this study, ferritin was the gold standard 
for measuring iron stores.
(ii) Low MCV and low MCH was defined as an MCV 
or MCH values that is below the lower limit of 
the age specific reference range.
Data analysis: The study population was described in 
terms of their demographic and clinical characteristics 
using means, medians and proportions. Prevalence 
of iron deficiency was calculated as proportion 
of children with ferritin values below -2SD of the 
reference mean. Children with iron deficiency were 
compared to those without to determine associated 
factors. Chi-square tests and t-test were used to 
determine factors with significant associations. Data 
was analysed using the Statistical Package for Social 
Sciences software (SSPS).
Ethical considerations: The hospitals’ ethics committees 
approved the study. Written consent was obtained 
from guardians for each participant after detailed 
explanation.
RESULTS
One hundred and twelve children were recruited 
into the study. Their ages ranged from one month 
to 17 years, with a median age of four years and five 
months. The mean age was 5 years 10 months. Males 
were 59 while 53 were female, giving a male to female 
ratio of 1:1. The commonest heart lesion encountered 
was Tetralogy of Fallot (54%).
  Fifty nine out of 112 patients (52.6%) were below 
five years of age, while 53 out of 112 (47.3%) were older 
than five years. The nutritional status was analysed 
based on the CDC 2000 guidelines. Twenty (17.9%) 
were classified as moderately stunted, while 25 (22.3%) 
were severely stunted. Moderate wasting was seen in 
17 (15.2%) of the study population while 23 (20.5%) 
were severely wasted (Table 1).
 Heart lesions were divided into those with 
predominantly left to right shunt and those with 
predominantly right to left shunt. Complex lesions 
seen in this study included dextrocardia and a 
host of other complicated cardiac anatomy lesions. 
The most frequently encountered heart lesion was 
Tetralogy of Fallot followed by tricuspid atresia 
(Table 2).
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Table 1
Summary of the characteristics of the study population (n=112)
Parameter Category No.  (%) 
Age (years) <1  20 17.8
 >1 – 5  39 34.8
 >5  – 12  35 31.3
 > 12  18 16.1
Sex Male 59 52
 Female 53 48
Nutritional status Normal and mild stunting  67 59.8
 Moderately stunted 20 17.9
 Severely stunted 25 22.3
 Normal and mild wasting  72 64.3
 Moderate wasting 17 15.2
 Severe wasting 23 20.5
Table 2
Frequency of encountered heart lesions (n=112)
Lesion No.  (%)
Predominantly right to left shunt  
  Tetralogy of fallot 61 54
  Tricuspid atresia 9 8
  Pulmonary atresia with VSD 6 5.3
  Double outlet right ventricle 4 3.5
  Critical pulmonary stenosis 3 2.6
Predominantly left to right shunt  
  Truncus arteriosus 2 1.7
  Transposition of great arteries 5 4.4
Eisenmengers and other complex 
heart lesions 22 19
Eighteen out of 106 patients had ferritin levels below 
the lower limit of their age specific reference ranges 
giving an iron deficiency prevalence of 16.9% (CI 
9.8-24.1%). Half the study population had MCV and 
MCH values below the age specific reference ranges 
(50.5% for low MCV and 50% for low MCH). Findings 
of microcytic hypochromic cells were seen in 33 out of 
106 patients giving a prevalence of 31.1% (Table 3).
 There was no statistically significant difference 
in the occurrence of any of the haematological 
derangements between the predominantly left to 
right shunting lesions and the predominantly right 
to left shunting lesions (Table 4).
Table 3
Summary of the haematological parameters
Parameter Mean (95% CI) Median Inter- Quartile Normal and  Derangements
   range acceptable values of interest
    No.    (%) No.    (%) 
     
Serum ferritin 48.9 (40.5-57.3) 39 61.25 88/106  83.1 18/106  16.9
MCV 76.3 (74.2-78.4) 77 17 51/103  49.5 52/103  50.5
MCH 25.8 (24.9-26.8) 25.45 7.17 51/102  50 51/102  50
Hypochromic 
microcytic cells    73/106  68.9 33/106  31.1
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 In this study all iron deficient patients fell in the 
group of children aged less than five years of age. 
This was statistically significant (p= 0.000). The other 
significant factor associated with iron deficiency was 
stunting, specifically, severe stunting. There was a five 
fold increased likelihood of having iron deficiency with 
the presence of severe stunting (odds ratio 4.88 [95% 
CI 1.48-16.2], p = 0.005). No statistically significant 
relationship was noted between iron deficiency and 
sex (p=0.301) and between iron deficiency and wasting 
(p=0.673) (Table 5).
Table 4
Influence of the type of heart lesion on the haematological derangements 
Parameter CCHD predominantly  CCHD predominantly  OR (95% CI) P-value
 Left to right shunt Right to left shunt
 No.    (%) No.  (%) No.  (%) 
Serum ferritin    
Iron deficiency 12/70  14.6 2/5  28.6 0.43  0.06-3.63 0.302
Rbc indicators    
Low MCV 36/82  43.9 2/7  28.6 1.96  0.31-15.57 0.690
Low MCH 22/82  26.8 1/7  14.3 2.20  0.24-51.26 0.690
PBF-Microcytic 
hypochromic cells 28/82  43.1 1/7  14.3 3.11  0.34-71.99 0.420
Table 5
Non-cardiac correlates of iron deficiency
Parameter Iron deficiency No iron deficiency OR 95% CI P-value 
No.    (%) No.    (%) 
Age     
  <60 months 18/18  100 41/94  43.6 - - 0.000
  ≥ 60 months 0/18   0 53/94  56.4   
Sex     
  Male 11/18  61.1 48/94  51 1.5 0.49-4.76 0.301
  Female 7/18   38.9 46/94  49   
Nutrition status     
stunting     
  Severe 9/18   50 16/94  17 4.88 1.48-16.2 0.005
  Moderate 1/18   5.5 19/94  20.2 0.22 0.01-1.85 0.19
  Mild to normal 8/18   44.5 59/94  62.8 0.47 0.15-1.46 0.23
Wasting     
  Severe 5/18   27.8 32/93  34.4 0.73 0.21-2.48 0.78
  Moderate 6/18   33.3 22/93  23.6 1.61 0.47-5.38 0.386
  Mild to normal 7/18   38.9 39/93  42.0 0.88 0.28-2.75 0.98
DISCUSSION 
The overall prevalence of iron deficiency in this 
study was 16.9%, which is almost similar to what 
was found in the study done in India by Gaiha   et al 
(3) where they reported a prevalence of 18.2% and 
much higher than the prevalence of 7% reported by 
Murila et al (6) in Kenya who looked at a generally 
healthy population of children less than 5 years of 
age. Interestingly, in our study all the 18 patients 
found to be iron deficient were below five years of 
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age. Drossos et al (7) from Italy in 1981 examining a 
total of 38 cyanotic heart disease children, found an 
iron deficiency prevalence of 12.5% in children 6 to 
12 years of age. Similarly, in the same study, children 
less than five years still contributed the bulk of the 
iron deficiency group with a prevalence of 37.5%. 
  Ferritin measurements as indicator of iron status 
are prone to giving false negative results as they 
are affected by many factors causing inflammation 
including infection. This leads to a falsely elevated 
ferritin level, thus the false negatives. In our local 
set up, with high prevalence of infectious diseases, 
it is possible that our ferritin assays could have 
underestimated the prevalence of iron depletion.
  From this study, we found that 40.1% (45 out 
of 112) children were stunted. This is much higher 
than the national figure of 30% reported in the Kenya 
Demographic and Health Survey (KHDS) 2003. Out of 
these, 22.3% were severely stunted while 17.9% were 
classified as moderately stunted. Wasting was seen in 
35.7% (40 out of 112) of our study population, a figure 
much higher than the national figure of 6% reported 
in the KHDS 2003. Severe wasting was seen in 20.5% 
of the study population while moderate wasting was 
seen in 15.2%. This was however an expected finding 
given the burden of the heart disease on its own is 
expected to interfere with growth and general well 
being and food intake. 
In conclusion, there is a high prevalence of 16.9% of 
iron deficiency in children with cyanotic heart disease 
attending the cardiac clinics at Kenyatta National 
Hospital and Mater Hospital.
We recomend that, children with cyanotic heart 
disease should routinely be screened for iron 
deficiency, using a combination of blood picture and 
ferritin levels and those found deficient should be 
treated accordingly.
REFERENCES
1. Cemile, B. O., Tansu, S., Betul, T., et al. Diagnosing 
iron deficiency in cyanotic heart disease. Indian J. 
Pediatrics. 2003; 70: 29-31.
2. Hutton, R.D. The effect of iron deficiency on whole 
blood viscosity in polycythaemic patients. Brit.  J. 
Haematol. 1979; 43:191-199.
3. Gaiha, M., Sethi, H. and Sudha, R. A clinico-
hematological study of iron deficiency anaemia 
and its correlation with hyperviscosity symptoms 
in cyanotic congenital heart disease. Indian Heart J. 
1993: 45: 53-55.
4. Perloff, J. K., Rosove, M. H. and Child, S.J. Adults 
with cyanotic congenital heart disease: Hematologic 
management. Annals Inter. Med. 1988;109: 406-413.
5. Behrman, R.E., Kliegman, R.M. and Jenson, H.B. 
Nelson Text Book of Pediatrics. W B Saunders 
Company. Philadelphia. 17th Edition 2004; 2406.
6. Murila, F.V., Macharia, W.M. and Wafula, E.M. Iron 
deficiency anaemia in children of a peri-urban health 
facility. East Afr. Med. J. 1999; 76: 520-523.
7. Drossos, C., Thanapoulos, B., Papadimitrou, A., 
et al. Incidence of anaemia in congenital heart 
disease. Med. Surg. Pediatrics. 1981; 3: 309-312.
 
